Cleared Traditional

K830186 - LYSIS +

K830186 is an FDA 510(k) clearance for LYSIS +, manufactured by Hematology Marketing Assoc.. The device is a Class 1 Pathology device with product code GGK cleared through the Traditional 510(k) pathway after a 40-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1983
Decision
40d
Days
Class 1
Risk

K830186 is an FDA 510(k) clearance for the LYSIS +. Classified as Products, Red-cell Lysing Products (product code GGK), Class I - General Controls.

Submitted by Hematology Marketing Assoc. (Walker, US). The FDA issued a Cleared decision on February 28, 1983 after a review of 40 days - a notably fast clearance cycle.

This device falls under the Pathology FDA review panel, regulated under 21 CFR 864.8540 - the FDA pathology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K830186

510(k) Number K830186 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 19, 1983
Decision Date February 28, 1983
Days to Decision 40 days
Submission Type Traditional
Review Panel Pathology (PA)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
38d faster than avg
Panel avg: 78d · This submission: 40d
Pathway characteristics
Predicate-based equivalence.

GGK Device Classification - Class 1, General Controls

Product Code GGK Products, Red-cell Lysing Products
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 864.8540
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - GGK Products, Red-cell Lysing Products

All 28
Devices cleared under the same product code (GGK) and FDA review panel - the closest regulatory comparables to K830186.
THROMBO PLUS
K834527 · W. Sarstedt, Inc. · Jan 1984
LYSING & HEMOGLOBIN S-REAGENT J & S
K833444 · Jasins & Sayles Associates, Inc. · Nov 1983
LYSING REAGENT
K832182 · Omega Medical Diagnostics · Aug 1983
RED CELL LYSING REAGENT 78N 1915-1
K822324 · Interscience, Inc. · Nov 1982
CDL LYSING REAGENT
K822500 · Connecticut Diagnostics, Ltd. · Sep 1982
CDL AUTO-LYSING REAGENT
K822504 · Connecticut Diagnostics, Ltd. · Sep 1982